期刊文献+

支气管哮喘患者血浆生物活性肽含量变化及其临床意义 被引量:4

Content change of bioactive peptide in blood of the patients with bronchial asthma
下载PDF
导出
摘要 作者采用放免分析法测定了14例支气管哮喘发作期患者血浆中神经肽,神经肽P物质、血管活性肠肽、内皮素一1含量,并以15例正常健康人做对照。发现支气管哮喘(以下简称哮喘)患者血浆中神经肽P物质、内皮素一1含量较正常健康人明显增高,血浆中血管活性肠肽含量较正常健康人明显降低。 ln this study,substance P(SP),vasoactive intestinal peptide(VIP )and endothelin(ET一1)in blcod in l 4 paients with bronchial asthma during acute stage were determined and 15heaIthy persons were used as a control group.The resuIt showed that SP and VIP in blood of the pa-tients were much higher than those of heaIthy people and that VIP in blood of the patiects was muchlower than that of heaIthy people. We further studied their parts in pathogenic mechanism of asthma.
出处 《白求恩医科大学学报》 CSCD 1996年第5期498-500,共3页 Journal of Norman Bethune University of Medical Science
关键词 P物质 血管活性肠肽 内皮素 哮喘 asthma substance P vasoactive intestinal peptide(VIP) endothelin(ET 1)
  • 相关文献

参考文献6

  • 1冯长顺,国外医学呼吸系统分册,1993年,13卷,1期,20页
  • 2李景吾,国外医学呼吸系统分册,1993年,13卷,3期,130页
  • 3马辑研,国外医学免疫学分册,1992年,4卷,171页
  • 4王山泽,支气管哮喘发病机理和防治进展,1991年
  • 5黄善生,国外医学病理生理分册,1988年,8卷,60页
  • 6张万会,朱运龙.P物质的免疫调节效应[J].生理科学进展,1992,23(2):116-121. 被引量:21

二级参考文献2

  • 1Dr. J. M. Lundberg,A. ?ngg?rd,J. Pernow,T. H?kfelt. Neuropeptide Y-, substance P- and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control[J] 1985,Cell and Tissue Research(1):9~18
  • 2John Foreman,Chris Jordan. Histamine release and vascular changes induced by neuropeptides[J] 1983,Agents and Actions(2-3):105~116

共引文献20

同被引文献34

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部